Pancreatic Cancer Research

ResearcherAzienda Ospedaliero-Universitaria CareggiActive in the last 2 years

Andrea Galli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5416-6290; OpenAlex author ID A5027938455. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. Co-author DOI 10.1001/jamanetworkopen.2026.35610↗
  2. The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 20… Co-author DOI 10.1186/s13045-026-01834-2↗
  3. Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration. Co-author DOI 10.3389/fonc.2025.1613773↗
  4. KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients. Co-author DOI 10.3389/fonc.2023.1295936↗
  5. Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression. Last author DOI 10.3892/ijo.2022.5345↗
  6. COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression. Last author DOI 10.1002/ijc.28502↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lorenzo Antonuzzo · 4 shared papers, 2022–2026 · strength 0.85
  2. Daniele Lavacchi · 3 shared papers, 2023–2026 · strength 0.72
  3. Serena Pillozzi · 3 shared papers, 2023–2026 · strength 0.72
  4. Simone Polvani · 4 shared papers, 2014–2025 · strength 0.57
  5. Elisa Giommoni · 2 shared papers, 2022–2026 · strength 0.44
  6. Giuseppe Defazio · 1 shared paper, 2025 · strength 0.24
  7. Tommaso Dall’Olio · 1 shared paper, 2026 · strength 0.18
  8. Valentina Arcangeli · 1 shared paper, 2026 · strength 0.18
  9. Erica Secchettin · 1 shared paper, 2026 · strength 0.18
  10. Marta Puzzono · 1 shared paper, 2026 · strength 0.18
  11. Carlo Ingaldi · 1 shared paper, 2026 · strength 0.18
  12. Paola Ghiorzo · 1 shared paper, 2026 · strength 0.18
  13. Giuliana Sereni · 1 shared paper, 2026 · strength 0.18
  14. Claudio Ricci · 1 shared paper, 2026 · strength 0.18
  15. Alberto Fantin · 1 shared paper, 2026 · strength 0.18
  16. Isabella M. Frigerio · 1 shared paper, 2026 · strength 0.18
  17. Francesco Maria Di Matteo · 1 shared paper, 2026 · strength 0.18
  18. Arianna Dal Buono · 1 shared paper, 2026 · strength 0.18
  19. Francesca Bergamo · 1 shared paper, 2026 · strength 0.18
  20. Giovanni Butturini · 1 shared paper, 2026 · strength 0.18
  21. Raffaele De Luca · 1 shared paper, 2026 · strength 0.18
  22. Giulia Martina Cavestro · 1 shared paper, 2026 · strength 0.18
  23. Lívia Archibugi · 1 shared paper, 2026 · strength 0.18
  24. Silvia Carrara · 1 shared paper, 2026 · strength 0.18
  25. Gabriele Capurso · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.